LI, YUN-LONG,YAO, WENQING,COMBS, ANDREW P.,YUE, EDDY W.,MEI, SONG,ZHU, WENYU,GLENN, JOSEPH,MADUSKUIE, THOMAS P. JR.,SPARKS, RICHARD B.,DOUTY, BRENT,HE, CHUNHONG
申请号：
RSP20170191
公开号：
RS55737B1
申请日:
2012.08.31
申请国别(地区):
RS
年份:
2017
代理人:
摘要：
The present invention provides heterocyclylamine derivatives of Formula I: wherein the variables are defined herein, that modulate the activity of phosphoinositide 3-kinases (PI3Ks) and are useful in the treatment of diseases related to the activity of PI3Ks including, for example, inflammatory disorders, immune-based disorders, cancer, and other diseases.
